IPX203-B13-02:Pharmacokinetics of IPX203 and Levodopa formulations in healthy volunteers

Trial Profile

IPX203-B13-02:Pharmacokinetics of IPX203 and Levodopa formulations in healthy volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Levodopa/carbidopa (Primary) ; Carbidopa; Entacapone; Entacapone; Levodopa; Levodopa/carbidopa/entacapone
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors IMPAX Laboratories; Impax Pharmaceuticals
  • Most Recent Events

    • 03 Apr 2014 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
    • 07 Nov 2013 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry record.
    • 10 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top